Financhill
Sell
28

IRTC Quote, Financials, Valuation and Earnings

Last price:
$178.53
Seasonality move :
14.14%
Day range:
$175.99 - $178.14
52-week range:
$86.19 - $212.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.99x
P/B ratio:
46.68x
Volume:
273.7K
Avg. volume:
478.2K
1-year change:
96.24%
Market cap:
$5.7B
Revenue:
$591.8M
EPS (TTM):
-$1.62

Analysts' Opinion

  • Consensus Rating
    iRhythm Technologies, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $218.60, iRhythm Technologies, Inc. has an estimated upside of 23.78% from its current price of $176.60.
  • Price Target Downside
    According to analysts, the lowest downside price target is $194.00 representing 100% downside risk from its current price of $176.60.

Fair Value

  • According to the consensus of 13 analysts, iRhythm Technologies, Inc. has 23.78% upside to fair value with a price target of $218.60 per share.

IRTC vs. S&P 500

  • Over the past 5 trading days, iRhythm Technologies, Inc. has overperformed the S&P 500 by 3.38% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • iRhythm Technologies, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • iRhythm Technologies, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter iRhythm Technologies, Inc. reported revenues of $192.9M.

Earnings Growth

  • iRhythm Technologies, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter iRhythm Technologies, Inc. reported earnings per share of -$0.16.
Enterprise value:
5.9B
EV / Invested capital:
6.85x
Price / LTM sales:
7.99x
EV / EBIT:
--
EV / Revenue:
8.34x
PEG ratio (5yr expected):
-0.57x
EV / Free cash flow:
180.68x
Price / Operating cash flow:
173.08x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$494.3M
Return On Assets:
-5.44%
Net Income Margin (TTM):
-7.33%
Return On Equity:
-54.18%
Return On Invested Capital:
-6.2%
Operating Margin:
-2.08%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $472.8M $560M $702.6M $147.5M $192.9M
Gross Profit $323.1M $379.9M $494.3M $101.5M $137.1M
Operating Income -$106.7M -$106.8M -$54.6M -$17.6M -$4M
EBITDA -$86.2M -$81.2M -$28.2M -$11.2M $2.6M
Diluted EPS -$3.45 -$4.86 -$1.62 -$1.48 -$0.16
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $325.2M $285.9M $234.3M $627.9M $680M
Total Assets $480.3M $440.4M $439.8M $909.7M $995.2M
Current Liabilities $82.8M $83.6M $102.3M $100.1M $146.9M
Total Liabilities $184.4M $201.2M $220M $837.9M $873.3M
Total Equity $295.8M $239.2M $219.8M $71.8M $121.9M
Total Debt $110.9M $116.4M $116.7M $719.8M $716.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$21.6M -$31.8M $73.9M $24.3M $34.9M
Cash From Investing -$10.7M $576K -$350.4M -$55.3M -$89.2M
Cash From Financing $8.5M $511.9M $12.6M -$35K $825K
Free Cash Flow -$55.6M -$72.4M $32.4M $15.5M $20.1M
IRTC
Sector
Market Cap
$5.7B
$28.2M
Price % of 52-Week High
83.3%
50.25%
Dividend Yield
0%
0%
Shareholder Yield
-0.22%
-1.54%
1-Year Price Total Return
96.24%
-18.1%
Beta (5-Year)
1.099
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $173.55
200-day SMA
Buy
Level $151.70
Bollinger Bands (100)
Buy
Level 167.25 - 182.23
Chaikin Money Flow
Buy
Level 28M
20-day SMA
Buy
Level $175.50
Relative Strength Index (RSI14)
Buy
Level 52.08
ADX Line
Buy
Level 13.74
Williams %R
Neutral
Level -36.3751
50-day SMA
Sell
Level $177.50
MACD (12, 26)
Sell
Level -0.57
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Neutral
Level 26.4M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.9122)
Sell
CA Score (Annual)
Level (-1.9525)
Buy
Beneish M-Score (Annual)
Level (-3.2811)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (2.9392)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

iRhythm Technologies, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Stock Forecast FAQ

In the current month, IRTC has received 11 Buy ratings 2 Hold ratings, and 0 Sell ratings. The IRTC average analyst price target in the past 3 months is $218.60.

  • Where Will iRhythm Technologies, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that iRhythm Technologies, Inc. share price will rise to $218.60 per share over the next 12 months.

  • What Do Analysts Say About iRhythm Technologies, Inc.?

    Analysts are divided on their view about iRhythm Technologies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that iRhythm Technologies, Inc. is a Sell and believe this share price will drop from its current level to $194.00.

  • What Is iRhythm Technologies, Inc.'s Price Target?

    The price target for iRhythm Technologies, Inc. over the next 1-year time period is forecast to be $218.60 according to 13 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is IRTC A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for iRhythm Technologies, Inc. is a Buy. 11 of 13 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of IRTC?

    You can purchase shares of iRhythm Technologies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase iRhythm Technologies, Inc. shares.

  • What Is The iRhythm Technologies, Inc. Share Price Today?

    iRhythm Technologies, Inc. was last trading at $178.53 per share. This represents the most recent stock quote for iRhythm Technologies, Inc.. Yesterday, iRhythm Technologies, Inc. closed at $176.60 per share.

  • How To Buy iRhythm Technologies, Inc. Stock Online?

    In order to purchase iRhythm Technologies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 29

Galecto, Inc. [GLTO] is down 12.13% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.

Sell
11
CDNAF alert for Dec 29

Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock